Panacea Life Sciences Holdings Inc (PLSH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 0 | 0 | 0 | 0 | 1 |
| Gross Profit | N/A | N/A | N/A | 0 | 1 |
| Operating Expenses | 2,436 | 3,125 | 1,602 | 382 | 412 |
| Operating Income | -2,436 | -3,125 | -1,602 | -382 | -411 |
| Interest Expense | 465 | 69 | 0 | 0 | 0 |
| Other Income | -1,437 | -667 | -1 | 32 | 121 |
| Pre-tax Income | -4,337 | -3,861 | -1,603 | -350 | -290 |
| Net Income Continuous | -4,337 | -3,861 | -1,603 | -350 | -290 |
| Net Income | $-4,337 | $-3,861 | $-1,603 | $-350 | $-290 |
| EPS Basic Total Ops | -25.49 | -25.49 | -17.93 | N/A | N/A |
| EPS Basic Continuous Ops | -25.50 | -25.49 | -18.69 | N/A | N/A |
| EPS Diluted Total Ops | -25.49 | -25.49 | -17.93 | N/A | N/A |
| EPS Diluted Continuous Ops | -25.50 | -25.49 | -18.69 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -25.49 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,031 | $-3,072 | $-1,602 | $-380 | $-409 |